文献速递慢阻肺

观察性研究中吸入糖皮质激素对慢阻肺疗效的偏倚教训

Observational Studies of Inhaled Corticosteroid Effectiveness in COPD: Lessons Learned.
PubMed 文献 · Chest · 2018-04-19

本文通过文献检索纳入21项观察性研究,评估ICS对慢阻肺患者死亡和住院等主要结局的有效性。发现9项研究受不死时间偏倚、5项受不可测量时间偏倚、7项受「哮喘因素」偏倚影响,这些偏倚导致ICS疗效被高估;而5项未受这些偏倚影响的研究未发现ICS与主要结局相关。

要点

  • 观察性研究设计缺陷可产生虚假的ICS疗效信号
  • 不死时间偏倚、不可测量时间偏倚和哮喘因素偏倚是主要问题
  • 无偏倚研究显示ICS对慢阻肺主要结局无显著关联

核心结论

  • 观察性研究可提供真实世界证据,但需合理设计避免偏倚。
  • 受偏倚影响的研究显示ICS降低慢阻肺主要结局风险,而无偏倚研究未发现关联。

研究设计与样本

  • 文献检索纳入21项观察性研究(包括队列和病例对照研究),评估ICS对慢阻肺患者死亡和住院等主要结局的有效性。

主要发现

  • 9项研究受不死时间偏倚影响,5项受不可测量时间偏倚影响,7项受「哮喘因素」偏倚影响,部分研究存在多种偏倚。
  • 受偏倚影响的研究汇总率比分别为0.71(95%CI 0.67-0.76)、0.76(95%CI 0.70-0.83)和0.79(95%CI 0.73-0.87)。
  • 5项未受这些主要偏倚影响的研究汇总率比为1.02(95%CI 0.88-1.17),未发现关联。

临床怎么用

  • 解读观察性研究时需评估是否存在不死时间偏倚、不可测量时间偏倚和哮喘因素偏倚。
  • 在开展长期昂贵的随机对照试验前,应仔细审查观察性研究信号。

局限性

  • 本文为文献综述,未报告原始研究的具体样本量、P值等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized controlled trials at times investigate findings suggested by observational studies. For example, the Towards a Revolution in COPD Health (TORCH) trial, which did not show a mortality reduction with inhaled corticosteroids (ICS) in COPD, was motivated by some observational studies that suggested considerable reductions in mortality with these drugs. Reasons for these discrepancies are unclear. METHODS: The literature was searched to identify all observational studies, including cohort and case-control studies, investigating the effectiveness of ICS on major outcomes in patients with COPD; these outcomes included death and hospitalization for COPD. RESULTS: A total of 21 studies were identified. Nine studies were affected by immortal time bias, five by immeasurable time bias, and seven by the "asthma factor" bias; some studies were affected by more than one bias. These studies found important reductions in the rates of major COPD outcomes with ICS use, with pooled rate ratios of 0.71 (95% CI, 0.67-0.76), 0.76 (95% CI, 0.70-0.83), and 0.79 (95% CI, 0.73-0.87), respectively, for the three sources of bias. In contrast, the five studies unaffected by these major biases did not find an association (pooled rate ratio, 1.02 [95% CI, 0.88-1.17]). CONCLUSIONS: Observational studies are important to provide evidence from real-world data on medication effects. However, appropriate study design and analysis are essential to avoid biases and ensure randomized trials with greater chances of success. The observational studies suggesting potential beneficial effects of nonrespiratory drugs to treat COPD, such as statins and beta-blockers, will also need careful review before long and expensive randomized trials are conducted.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Suissa S, Ernst P. Observational Studies of Inhaled Corticosteroid Effectiveness in COPD: Lessons Learned. Chest. 2018. PMID: 29679596. doi:10.1016/j.chest.2018.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。